Recent News

• 09.15.2025 - Medtronic Announces Pricing of €1.5 Billion of Senior Notes
• 09.15.2025 - Medtronic initiates global pivotal study of cardiac pacing in a new patient population
• 09.15.2025 - Medtronic initiates global pivotal study of cardiac pacing in a new patient population
• 09.04.2025 - Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
• 09.02.2025 - FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
• 08.29.2025 - Medtronic executives to speak at upcoming investor conferences
• 08.19.2025 - Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
• 08.19.2025 - Medtronic reports first quarter fiscal 2026 financial results

Recent Filings

• 09.15.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.15.2025 - FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
• 09.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - ARS Annual Report to Security Holders
• 09.03.2025 - 144 Report of proposed sale of securities
• 08.26.2025 - IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
• 08.26.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - DEF 14A Other definitive proxy statements
• 08.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material